This Peptide Could Be Causing Cancer 🤯
A speaker expresses strong opposition to the peptide BPC-157, explaining that its mechanism of inducing vascularization could potentially feed cancer cells. They also highlight the dangers of TB500, part of the popular 'Wolverine stack,' which was cut from FDA human trials due to safety concerns.
Summary
The speaker openly states their opposition to peptides, particularly BPC-157 (Body Protection Compound 157), which is currently one of the most widely used peptides. BPC-157 is marketed for cartilage health and recovery, working by inducing vascularization — the formation of new blood vessels around injured cells to deliver oxygen and nutrients.
However, the speaker raises a critical concern: BPC-157 cannot distinguish between healthy injured tissue and cancer cells. Since cancer tumors also rely on the formation of new blood vessels (angiogenesis) to grow and survive, the vascularization induced by BPC-157 could inadvertently accelerate cancer growth. The speaker argues that many people taking peptides are unaware of these potential risks.
Additionally, the speaker references the 'Wolverine stack,' a popular combination that includes TB500. They note that TB500 was found to be too dangerous to continue in human studies, leading the FDA to halt its development. This is cited as a reason why there are no randomized controlled trials supporting the safety of these compounds.
Key Insights
- The speaker argues that BPC-157 promotes vascularization indiscriminately, meaning it cannot distinguish between healthy tissue and cancerous cells, potentially supplying cancer tumors with the blood vessels they need to grow.
- The speaker explains that cancer survival and growth depend on the formation of new blood vessels, making BPC-157's vascularization mechanism a potential risk factor for accelerating cancer progression.
- The speaker claims that many people currently taking peptides are unaware of the harmful risks associated with them.
- The speaker states that TB500, part of the widely used 'Wolverine stack,' was found to be too dangerous to proceed in human studies, resulting in the FDA cutting it entirely from further development.
- The speaker points to the absence of any randomized controlled trials as evidence of the unproven and potentially dangerous nature of these peptides.
Topics
Full transcript available for MurmurCast members
Sign Up to Access